Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

Agios maintains a robust balance sheet and is positioned for significant growth if regulatory approvals and market expansion ...

The thalassemias are an inherited group of heterogeneous anemias in which 1 or more of the globin chains in the hemoglobin tetramer are absent. Among the 4 classic alpha thalassemia syndromes, there ...

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today ...

//(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Alpha Thalassemia pipeline constitutes 4+ key companies continuously working towards developing 5+ Alpha Thalassemia ...

(Las Vegas, Nevada, United States) As per DelveIns ight’s assessment, globally, Alpha Thalassemia pipeline constitutes 4+ key companies continuously working towards developing 5+ Alpha Thalassemia ...

Agios Pharmaceuticals (AGIO) announced that new data on mitapivat, an oral pyruvate kinase activator, will be featured in oral and poster ...

Alpha Thalassemia Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market ...

Researchers from Mahidol University have developed a rapid, high-throughput screening method for prevention and control of thalassemia. The related report by Munkongdee et al, "Rapid diagnosis of ...

People with the thalassemia trait, or thalassemia carriers, may not experience any symptoms. However, some thalassemia carriers can experience anemia symptoms, such as paleness and fatigue. In people ...